NO20040321L - 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar - Google Patents

5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar

Info

Publication number
NO20040321L
NO20040321L NO20040321A NO20040321A NO20040321L NO 20040321 L NO20040321 L NO 20040321L NO 20040321 A NO20040321 A NO 20040321A NO 20040321 A NO20040321 A NO 20040321A NO 20040321 L NO20040321 L NO 20040321L
Authority
NO
Norway
Prior art keywords
photosensitizers
ulcers
aminolevulinic acid
photochemistry
esters
Prior art date
Application number
NO20040321A
Other languages
English (en)
Norwegian (no)
Inventor
Jo Klaveness
Vidar Hansson
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of NO20040321L publication Critical patent/NO20040321L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20040321A 2001-07-26 2004-01-23 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar NO20040321L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118251.8A GB0118251D0 (en) 2001-07-26 2001-07-26 Method
PCT/GB2002/003386 WO2003011265A2 (en) 2001-07-26 2002-07-25 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds

Publications (1)

Publication Number Publication Date
NO20040321L true NO20040321L (no) 2004-03-19

Family

ID=9919248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040321A NO20040321L (no) 2001-07-26 2004-01-23 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar

Country Status (13)

Country Link
US (1) US20040259949A1 (es)
EP (1) EP1414430A2 (es)
JP (1) JP2005501050A (es)
KR (1) KR20040030863A (es)
CN (1) CN1533271A (es)
CA (1) CA2454136A1 (es)
CZ (1) CZ2004257A3 (es)
GB (1) GB0118251D0 (es)
HU (1) HUP0401192A3 (es)
MX (1) MXPA04000647A (es)
NO (1) NO20040321L (es)
RU (1) RU2004105655A (es)
WO (1) WO2003011265A2 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
NL1020336C2 (nl) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Toepassing van een verbinding voor de bereiding van een farmaceutisch preparaat voor het behandelen van brandwonden, en een werkwijze voor het behandelen van brandwonden.
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0420888D0 (en) * 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
ATE454146T1 (de) * 2006-08-29 2010-01-15 Stichting Tech Wetenschapp Pharmazeutische zusammensetzung zur behandlung von mykotischen hauterkrankungen und verfahren zu ihrer herstellung
CA2709274A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
CA3095369C (en) * 2008-04-04 2023-09-26 Immunolight, Llc Non-invasive systems and methods for in-situ photobiomodulation
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
EP3042647B1 (en) 2009-06-11 2020-08-26 Photocure ASA Semi-solid compositions and pharmaceutical products comprising 5-aminolevulinic acid esters
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
WO2011107478A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
WO2011161220A1 (en) 2010-06-23 2011-12-29 Photocure Asa Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
WO2012004399A1 (en) 2010-07-09 2012-01-12 Photocure Asa Dry compositions and devices containing such dry compositions for use in photodynamic therapy or photodynamic diagnosis
CN103189105A (zh) * 2010-07-21 2013-07-03 P·傅贾尔斯 治疗慢性创伤的光活性维生素纳米颗粒
NZ612533A (en) * 2010-12-06 2015-03-27 Univ British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
JP6323978B2 (ja) 2010-12-24 2018-05-16 アークレイ株式会社 癌細胞の検出方法
KR101254758B1 (ko) * 2011-02-28 2013-04-15 부산대학교병원 광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
KR101254752B1 (ko) * 2011-02-28 2013-04-15 부산대학교 산학협력단 광역동치료의 광증감제로 사용하기 위한 구연산을 이용한 아미노레불리닉산 트라이머
EP2722041B1 (en) 2011-06-16 2018-10-24 SBI Pharmaceuticals Co., Ltd. Therapeutic agent for allergic rhinitis
US20140276107A1 (en) 2011-10-14 2014-09-18 Photocure Asa Photodynamic diagnosis
WO2013053904A1 (en) 2011-10-14 2013-04-18 Photocure Asa Stent
JP2015500717A (ja) 2011-12-19 2015-01-08 フォトキュア エイエスエイ 照射装置
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス,インコーポレイテッド 創傷充填デバイスおよび方法
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
PL3011972T3 (pl) * 2013-06-19 2020-02-28 Sbi Pharmaceuticals Co., Ltd. Kompozycja medyczna do pobudzania syntezy protoporfiryny ix
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
RU2604399C1 (ru) * 2015-12-01 2016-12-10 Сергей Владимирович Москвин Способ лазерной терапии больных трофическими язвами
RU2661084C1 (ru) * 2017-07-21 2018-07-11 Федеральное Агентство Научных Организаций Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ комплексного лечения пролежней у пациентов с длительной иммобилизацией
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CN112062713B (zh) * 2020-08-04 2023-03-31 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds

Also Published As

Publication number Publication date
HUP0401192A3 (en) 2005-07-28
WO2003011265A3 (en) 2003-04-24
CA2454136A1 (en) 2003-02-13
CN1533271A (zh) 2004-09-29
EP1414430A2 (en) 2004-05-06
MXPA04000647A (es) 2004-05-17
US20040259949A1 (en) 2004-12-23
GB0118251D0 (en) 2001-09-19
CZ2004257A3 (cs) 2004-08-18
KR20040030863A (ko) 2004-04-09
JP2005501050A (ja) 2005-01-13
HUP0401192A2 (hu) 2004-12-28
RU2004105655A (ru) 2005-04-10
WO2003011265A2 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
NO20040321L (no) 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar
Li et al. Complications of negative pressure wound therapy: a mini review
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
DE60114882D1 (de) System zum einbringen einer chirurgischen schlinge
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
DK0784429T3 (da) Terapeutiske kombinationer af venöse dilatorer og arterielle dilatorer
JP2016529231A (ja) 医学的状態と疾患を治療するようにプラズマ状態の一酸化窒素を利用する方法
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
DK0396184T3 (da) Anvendelse af ketoconazol og et retinoid til behandling af acne vulgaris
DE602007008385D1 (de) Verwendung von valproinsäure zur topischen behandlung von leichter bis mittelschwerer akne vulgaris
RU2020140481A (ru) Спрей на основе транексамовой кислоты для артропластики коленного сустава
WO2021243183A8 (en) Formulations and methods for treating acute respiratory distress syndrome, asthma, or allergic rhinitis
DK1154766T3 (da) Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B
RU2466687C1 (ru) Способ радикального лечения острого варикотромбофлебита нижних конечностей с использованием лазерной и плазменной технологий
JOP20190276A1 (ar) طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
WO2008096816A1 (ja) 血管新生誘導剤及びそれに用いられるポリペプチド
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
RU2460555C1 (ru) Способ лечения ожоговых ран
WO2023122100A3 (en) Methods and systems for treating mucosal dysfunction and other medical conditions of a patient
PL1818052T3 (pl) Zastosowanie formoterolu w profilaktycznym i/lub terapeutycznym leczeniu wyniszczenia mięśniowego i/lub zespołu wyniszczenia, związanych ze stanami katabolicznymi w przebiegu niektórych chorób, takich jak nowotwory, AIDS, zakażenia, cukrzyca i inne
DE60011598D1 (de) Behandlung von hypersensibilitätreaktion erkrankungen
US8093215B2 (en) Method for restructuring a biological tissue comprising collagen fibrils and relative uses
ATE476974T1 (de) Verwendung einer kombination von l-carnitin, acetyl l-carnitin und propionyl l-carnitin zur behandlung von oligoasthenoteratospermia
RU2475280C2 (ru) Способ предотвращения осложнений эндовазальной лазерной коагуляции при лечении варикозной болезни нижних конечностей

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application